Search Results for "Janssen Ortho August 2010"
Matching Channels
The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...
Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...
Swine flu is the common name given to a relatively new strain of influenza (flu) that caused a flu pandemic in 2009-2010. It is also referred to as H1N1 influenza (because it is the H1N1 strain of...
Matching News
Mylan announces Ortho Tri-Cyclen Lo settlement agreement with Janssen Pharmaceuticals
Mylan has entered into a settlement agreement with Janssen Pharmaceuticals that will resolve patent litigation related to Norgestimate/Ethinyl Estradiol Tablets 0.180 mg/0.025 mg, 0.215 mg/0.025 mg...
Glenmark settles with Janssen on Ortho Tri-Cyclen Lo for launch alongside Teva, Watson
Glenmark expects to launch norgestimate and ethinyl estradiol tablets, a generic version of Janssen Pharmaceuticals' oral contraceptive Ortho Tri-Cyclen Lo, in the US at the end of 2015, following a s...
Mylan, Janssen agree to settle Ortho Tri-Cyclen Lo patent litigation
Mylan along with Famy Care has signed a settlement agreement with Janssen Pharmaceuticals to resolve patent litigation related to Norgestimate/Ethinyl Estradiol tablets 0.180 mg/0.025 mg, 0.215 mg/0.0...
FDA OKs Lupin'sgeneric of Janssen oral contraceptive
Lupin has made another significant step forward in developing its position in the US oral contraceptives market with a US FDA approval for generic versions of Janssen Pharmaceuticals' oral contracept...
Mylan Enters Into Settlement Deal With Janssen On Ortho Tri-Cyclen Lo Tablets
CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) announced Thursday that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent li...
US FDA approves Janssen's Simponi to treat ulcerative colitis
The US Food and Drug Administration late yesterday (May 15) approved a new use for Johnson & Johnson (NYSE: JNJ) subsidiary Janssen Ortho Biotech's Simponi (golimumab) injection, to treat adults with...
Janssen, Health 2.0 announce partnership
Today Janssen Healthcare Innovation (JHI), a team within Janssen Research & Development, LLC. (Janssen), announced the Janssen Connected Health Challenge Europe 2012 in partnership with Health 2.0.
Mylan Announces Ortho Tri-Cyclen Lo Settlement Agreement
PITTSBURGH, Nov. 8, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that wil...
Matching PubMed Articles
Substituted benzoannulated spiroacetals were prepared from (2-haloaryl)alkyl alcohols and dihydropyranyl or dihydrofuranyl pinacol boronates using a Suzuki-Miyaura coupling followed by an acid-catalyz...
Science signaling podcast: 24 august 2010.
This is a conversation with Michael Comb about a Research Article published in the 24 August 2010 issue of Science Signaling.
Science signaling podcast: 3 august 2010.
This is a conversation with Martine Smit about a Research Article published in the 3 August 2010 issue of Science Signaling.
A practical ortho,meta, (or even ortho,ortho') magnesiation of trifluoroacetamides of anilines, aminopyridines, and aminopyrazines at room temperature was performed with TMPMgCl⋅LiCl or TMP(2) Mg⋅...
Ortho lithiation of N-benzamido-P,P,P-triaryliminophosphoranes through deprotonation with alkyllithium bases was achieved with ortho-C horizontal lineO and ortho-P horizontal lineN chemoselectivity. H...